-
Clonal Evolution and Blastic Plasmacytoid Dendritic Cell Neoplasm - Two Cases
Study
EGAS50000000214
-
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
Study
EGAS50000001269
-
single-cell RNA-Seq of colorectal cancer patient samples
Study
EGAS00001006665
-
Dynamics of checkpoint receptors in γδ T cell subsets are associated with clinical responses during anti-PD-1 immunotherapies
Study
EGAS50000001270
-
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
Study
EGAS50000001272
-
Broad utility of ultrasensitive analysis of ctDNA dynamics across solid tumors treated with immunotherapy
Study
EGAS50000001271
-
BAP1 study
Study
EGAS50000000235
-
DNA Replication Speed controls Epigenome Integrity and T Cell Fate
Study
EGAS50000001273
-
Oxel Pilot Study
Study
EGAS50000000222
-
A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy
Study
EGAS50000000228
-
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual disease
Study
EGAS50000000215
-
Neversmoker lung adenocarcinoma
Study
EGAS50000000232
-
Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases
Study
EGAS50000000225
-
Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer
Study
EGAS50000000212
-
Detailed molecular and immune marker profiling of archival prostate cancer samples
Study
EGAS00001004396
-
GBM stem cell lines and PRMT5 inhibitor
Study
EGAS00001004397
-
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
Study
EGAS50000000211
-
Sensitive circulating tumor DNA based residual disease detection in epithelial ovarian cancer
Study
EGAS50000000245
-
RNA sequencing of serial samples from patients enrolled in the NA-PHER2 trial
Study
EGAS50000000248
-
Localised colon cancer WES study contaning WBCs, tissue and plasma samples at different time points
Study
EGAS50000000204
-
Panel sequencing of endocrine-resistant breast cancer
Study
EGAS50000000236
-
Accelerated single cell seeding in relapsed multiple myeloma
Study
EGAS00001004404
-
A fast, affordable and minimally-invasive diagnostic test for Cancer of Unknown Primary (CUP) using DNA methylation profiling
Study
EGAS50000000257
-
DNTR sequencing data of paediatric acute lymphoblastic leukemia
Study
EGAS50000001247
-
Homopolymer switches mediate adaptive mutability in mismatch repair-deficient colorectal cancer
Study
EGAS50000000297
-
CD8-targeted IL-2 unleashes tumor-specific immunity in human cancer tissue by reviving the dysfunctional T cell pool
Study
EGAS00001007712
-
BRCA1 secondary splice-site mutations
Study
EGAS50000000022
-
WGS of cord blood hematopoietic stem and progenitor cells
Study
EGAS50000000288
-
STM4 - Mouliere et al, 2018. Enhanced detection of circulating tumor DNA by fragment size analysis
Study
EGAS00001004418
-
Somatic mutations of non-malignant T cells
Study
EGAS50000000237
-
INTEGRATIVE MOLECULAR ANALYSIS OF SKIN TUMORS FROM CYLD CUTANEOUS SYNDROME PATIENTS
Study
EGAS50000000247
-
Comprehensive peripheral blood immunoprofiling reveals five immunotypes with immunotherapy response characteristics in cancer patients
Study
EGAS50000000286
-
Molecular underpinnings of dedifferentiation and aggressiveness in chromophobe renal cell carcinoma
Study
EGAS50000000287
-
Whole Genome Sequencing of HER2-Positive Metastatic Extramammary Paget’s Disease: A Case Report
Study
EGAS50000000243
-
Heterogeneity and evolution of DNA mutation rates in microsatellite-stable colorectal cancer
Study
EGAS50000000284
-
The neo-open reading frame peptides that comprise the tumor framome are a rich source of neoantigens for cancer immunotherapy
Study
EGAS00001006021
-
Transcriptomic profiling of prostate cancer metastasis xenograft models reveals conservation of bone microenvironment signatures
Study
EGAS00001004770
-
Lipomatous tumors with 12q amplification
Study
EGAS50000000062
-
resistance to FGFR inhibitor in FGR2 cancers from DNA sequencing
Study
EGAS50000000305
-
Platinum-based chemotherapy induces opposing effects on immunotherapy response-related spatial and stromal biomarkers in the bladder cancer microenvironment
Study
EGAS50000000309
-
Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma
Study
EGAS00001004430
-
HiDEF-seq single-molecule sequencing of single-strand mismatches and damage
Study
EGAS50000000318
-
single cell data from HPV-positive head and neck cancer patients receiving induction CTLA-4 and PD-1 immune checkpoint blockade
Study
EGAS50000000335
-
Non-invasive prediction of immunotherapy response (NIPIT) project
Study
EGAS50000000266
-
Paired Biopsy Project: West Coast Dream Team
Study
EGAS50000000327
-
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS50000000106
-
Systematic dissection of tumor-normal single-cell ecosystems across a thousand tumors of 30 cancer types
Study
EGAS50000000324
-
ROBUST (NCT02285062)
Study
EGAS50000000333
-
Single cell transcriptomic profiles of advanced melanoma patients treated with checkpoint inhibitor immunotherapy
Study
EGAS50000000339
-
Decoding Human Endogenous Retrovirus Expression in Liver Metastatic Colorectal Cancers: Implications for Diagnosis and Prognosis
Study
EGAS50000000307
-
A single-cell multi-omic atlas of nodal B-cell non-Hodgkin lymphomas
Study
EGAS50000000342
-
WES analysis of tumor samples
Study
EGAS50000000430
-
Spatially Resolved Tumor Ecosystems and Cell States in Gastric Adenocarcinoma Progression and Evolution
Study
EGAS50000000345
-
Targeted capture, whole genome sequencing, and RNAseq to identify rearrangements in B-cell lymphomas
Study
EGAS50000000328
-
Single cell RNAseq of PBMC from bladder cancer patients
Study
EGAS00001004458
-
Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness
Study
EGAS50000000355
-
Clinical and molecular features of early onset pancreatic cancer
Study
EGAS50000000362
-
The evolution of ovarian high grade serous carcinoma from STIC lesions
Study
EGAS50000000361
-
Circulating tumor DNA dynamics reveal KRAS G12C mutation heterogeneity and response to treatment with the KRAS G12C inhibitor divarasib in solid tumors
Study
EGAS50000000315
-
Single-cell RNA sequencing of human skin tumors (BCC, SCC and Melanoma)
Study
EGAS50000000365
-
Diagnosis of pediatric central nervous system tumors using methylation profiling of cfDNA from cerebrospinal fluid
Study
EGAS50000000377
-
Patient-derived models of primary breast cancer for preclinical development of novel neoadjuvant therapies
Study
EGAS50000000398
-
TOTHER3
Study
EGAS50000000385
-
Colorectal cancer functional annotation - MPRA
Study
EGAS50000000406
-
Heterogeneity and evolution of DNA mutation rates in microsatellite-stable colorectal cancer
Study
EGAS50000000425
-
AYA glioma NGS
Study
EGAS50000000383
-
Genomic characterization of retinoblastoma
Study
EGAS00001005248
-
Surgery in combination with immune checkpoint therapy as an effective treatment for patients with metastatic cancer.
Study
EGAS00001005667
-
Gene Expression Signature in Normal Mammary Gland from 83 Breast Cancer Patients Indicates Pre-tumorous Changes and Adverse Outcomes
Study
EGAS50000000011
-
Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma.
Study
EGAS50000000395
-
Uncovering the potential of circulating tumor DNA for pediatric precision oncology
Study
EGAS50000000393
-
Colorectal cancer cells possess an equipotent capacity to enter a developmental pausing-like state to survive chemotherapy
Study
EGAS00001004773
-
Non-KMT2Ar infant Acute Lymphoblastic Leukemia Sequencing
Study
EGAS50000000405
-
Targeted DNA sequencing and mRNA sequencing data from patients with peritoneal metastasis from colorectal cancer
Study
EGAS50000000404
-
Array-based methylation analysis of SDHB-deficient pheochromocytoma and paraganglioma
Study
EGAS00001007844
-
plasma DNA LINE-1 targeted bisulfite sequencing: a new non-invasive multi-cancer detection marker
Study
EGAS50000000446
-
Tumor inflammation and mutational burden are differentially associated with response to nivolumab or nivolumab plus ipilimumab in metastatic colorectal cancer
Study
EGAS50000000416
-
DNA methylation database for gynecological cancer detection, classification and assay development
Study
EGAS50000000417
-
Systematic Growth Factor Profiling Platform for 3D Tumor Models Reveals EstradiolResponsive Cellular Mechanisms of Immunotherapy Resistance
Study
EGAS50000000422
-
Molecular analysis of CRC in patients with Primary Sclerosing Cholangitis (PSC) and Inflammatory Bowel Disease (IBD)
Study
EGAS00001004497
-
Cergentis FFPE-TLC
Study
EGAS50000000427
-
Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial
Study
EGAS50000000387
-
Genomic and clinical characterization of a familial GIST kindred intolerant to imatinib
Study
EGAS50000000372
-
Copy number variations and fragmentation features in cell-free DNA predict response in advanced non-small cell lung cancer patients under anti-PD-(L)1 therapy
Study
EGAS50000000441
-
A 3D genome atlas of breast cancer progression (BRCA3D)
Study
EGAS50000000444
-
Multiple Myeloma GWAS Meta-analysis
Study
EGAS50000000292
-
Multi-omic analysis of SDHB-related PCPG
Study
EGAS50000000346
-
Genome and transcriptome sequencing of cancer of unknown primary tumours
Study
EGAS50000000452
-
Circulating immune cell landscape in colorectal cancer patients
Study
EGAS50000000590
-
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer (NABUCCO Cohorts 1 and 2)
Study
EGAS00001004521
-
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibition
Study
EGAS50000000426
-
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
Study
EGAS00001004525
-
Drug Development against Tumor Microtube Networks in Glioblastoma
Study
EGAS50000000477
-
Personalized peptide vaccination among 173 patients with IDH wildtype glioblastoma: a retrospective analysis
Study
EGAS50000000449
-
Prognostic whole-genome and transcriptome signatures in colorectal cancers
Study
EGAS50000000124
-
Identifying New Genetic Subtypes in Follicular Lymphoma
Study
EGAS50000000435
-
Spatially resolved niche and tumor microenvironmental alterations in gastric cancer peritoneal metastases
Study
EGAS50000000501
-
Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard and high risk myeloma
Study
EGAS00001004558
-
SCLC MeDIP
Study
EGAS50000000506
-
Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer
Study
EGAS50000000607